GleamWall
中文EN

STME Stimcell Energetics Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1493712 · Fiscal year ends 05/31

Financial factors as of 2026-08-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-4.5%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-2,067.1%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets3,334.9%
Debt / equity—
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.39x
Accruals ratio-1,257.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q1*2026-08-312026Q4*2026-05-312026Q3*2026-02-282026Q2*2025-11-302026Q1*2025-08-312025Q4*2025-05-312025Q3*2025-02-282025Q2*2024-11-30
Income statement
Revenue————————
SG&A expense$67,296$71,270$8,208$163,598$139,484$141,473$32,847$22,681
Interest expense$22,960$20,740$18,658$16,702$13,248$11,143$9,451$8,810
Net income-$169,518-$229,459-$90,566-$309,748-$265,602-$219,329-$140,537-$139,508
EPS (basic)-0.01—0.00-0.01-0.01—-0.01-0.01
EPS (diluted)————————
Balance sheet
Cash & equivalents$6,883$3,057$10,257$46,159$6,437$14,581$6,678$33,821
Total assets$60,946$81,454$34,521$52,345$16,387$21,222$17,110$38,346
Total liabilities$2.03M$1.89M$1.71M$1.59M$1.41M$1.27M$1.09M$1.02M
Shareholders' equity-$1.97M-$1.81M-$1.68M-$1.54M-$1.39M-$1.25M-$1.07M-$982,705
Cash flow statement
Operating cash flow-$108,995-$43,511-$86,290-$74,138-$108,142-$58,448-$43,716-$16,519
Financing cash flow$112,826$36,334$50,000$114,248$100,000$66,113$16,745$30,000

Free plan shows the latest 8 periods; Pro shows all 65 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.